Skip to main navigation Skip to search Skip to main content

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

  • Daniel Blanco-Melo
  • , Benjamin E. Nilsson-Payant
  • , Wen Chun Liu
  • , Skyler Uhl
  • , Daisy Hoagland
  • , Rasmus Møller
  • , Tristan X. Jordan
  • , Kohei Oishi
  • , Maryline Panis
  • , David Sachs
  • , Taia T. Wang
  • , Robert E. Schwartz
  • , Jean K. Lim
  • , Randy A. Albrecht
  • , Benjamin R. tenOever

Research output: Contribution to journalArticlepeer-review

3351 Scopus citations

Abstract

In comparison to other respiratory viruses, SARS-CoV-2 infection drives a lower antiviral transcriptional response that is marked by low IFN-I and IFN-III levels and elevated chemokine expression, which could explain the pro-inflammatory disease state associated with COVID-19.

Original languageEnglish
Pages (from-to)1036-1045.e9
JournalCell
Volume181
Issue number5
DOIs
StatePublished - 28 May 2020

Keywords

  • COVID-19
  • Coronavirus
  • IL6
  • SARS-CoV-2
  • chemokines
  • ferret
  • interferon
  • transcriptomics
  • virus-host interactions

Fingerprint

Dive into the research topics of 'Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19'. Together they form a unique fingerprint.

Cite this